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Background: Type B aortic dissections are being successfully treated by thoracic endovascular aortic repair (TEVAR).
Postoperative false lumen patency has been associated with aneurysmal dilatation and rupture of the thoracic aorta,
necessitating further intervention. This is the first volumetric analysis of type B aortic dissections comparing patients with
and without false lumen thrombosis (FLT) after TEVAR. We hypothesized that a greater increase in postoperative true
lumen volume will lead to FLT, and without this change, false lumen patency will result.
Methods: Preoperative and postoperative computed tomography angiography (CTA) imaging was analyzed using
three-dimensional reconstruction tomeasure the short- and long-axis diameter and cross-sectional area of the true lumen,
false lumen, and total aorta. Measurements were taken at 5-cm intervals from the left subclavian artery to the aortic
bifurcation. Pre- and postoperative volumetric data were calculated and compared in patients with and without
postoperative FLT.
Results: Between 2006 and 2010, 132 patients underwent thoracic aortic stent grafting. Of these, 31 (23%) had thoracic
endografting for type B aortic dissection. Pre- and postoperative CTA images were available for analysis in 23 patients
with a mean age of 59  14 years treated for acute, complicated (n  8, 35%), and chronic (n  15, 65%) indications.
Mean follow-up imaging was 9 months (range, 1-39 months). Thirteen patients (56%) had postoperative FLT and 10
(43%) had persistent false lumen patency. The dissections involved the left subclavian artery (n  12), visceral arteries
(n  14), renal arteries (n  16), and iliac arteries (n  15). The left subclavian artery was intentionally covered in 15
patients (65%). There were no significant differences in age, acute vs chronic dissection, branch vessel involvement,
coverage of the left subclavian artery, or distal extent of the endograft between patients with and without postoperative
FLT. Patients with postoperative FLT had a significantly smaller preoperative maximum thoracic aortic diameter
(5.05  1.0 vs 6.30  1.4 cm; P  .02). Volumetric analysis demonstrated significantly smaller preoperative true lumen
volume (141.3  68 vs 230.5  92 cm3; P  .01) in patients with FLT, but no difference in preoperative false lumen
volume. Patients with FLT had a significant increase in the volume percentage of the true lumen from 42.7% to 61.7%
(P  .02) after stent graft repair, compared with an increase from 46.7% to 47.7% (P  .75) in patients with persistent
false lumen patency.
Conclusions: This volumetric study of type B aortic dissection treated with TEVAR suggests that the ability of the
endograft to significantly increase the true lumen volume as a percent of the total aorta most accurately predicts
postoperative FLT. This is best demonstrated in a nonaneurysmal dissection regardless of timing since dissection. (J Vasc
Surg 2011;54:985-92.)
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tStanford type B aortic dissection remains a devastating
condition with significant early and late morbidity and
mortality.1-6 Acute, complicated type B dissection carries
the gravest prognosis. Surgical intervention is indicated for
patients presenting with visceral or distal ischemia (malper-
fusion syndrome), rupture, uncontrolled hypertension, or
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doi:10.1016/j.jvs.2011.03.263efractory pain.2,5,6 Alternatively, patients with uncompli-
ated and chronic dissections have traditionally been man-
ged medically.1,3-6 However, this has not been proven to
mprove long-term survival, and without intervention,
hese patients remain at risk for late aneurysmal degenera-
ion and aortic rupture.5-7 As success has been demon-
trated with endovascular grafting in the thoracic aorta with
ower morbidity and mortality compared with open sur-
ery,5,7,8 the threshold for intervention in these patients
as lowered. Currently, indications for repair in the chronic
etting include aneurysmal degeneration, rapid expansion
5 mm/6 months), rupture, and refractory pain.1-3,11,12
The efficacy of thoracic endovascular aortic repair
TEVAR) in the management of both acute and chronic
ype B dissection has been demonstrated.5,7-12 The goals of
tent graft placement are to cover the proximal intimome-
ial tear, re-expand the true lumen, and exclude the false
umen. Blood flow is thereby diverted preferentially to the
rue lumen, normalizing antegrade arterial flow. When
uccessful, this therapy results in thrombosis and eventual
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October 2011986 Stanley et alobliteration of the false lumen. Multiple studies have doc-
umented that false lumen thrombosis (FLT) portends a
better long-term prognosis, and this has become a primary
outcome measure for TEVAR in the setting of type B
dissections.13-15 It is thought that persistent false lumen
filling maintains pressurization of the thin, weak false lu-
men wall leading to aneurysmal dilatation and potentially
aortic rupture.13-15
Nonetheless, while FLT remains a goal of TEVAR for
the treatment of dissections, we cannot reliably predict this
outcome. In this retrospective review, we sought to identify
pre- and postoperative aortic morphology in type B dissec-
tion that may contribute to FLT following TEVAR. These
data may be useful to determine which patients are likely to
have successful outcomes following TEVAR.
METHODS
Patients. Patients presenting at our institution from
January 2006 to March 2010 with Stanford type B aortic
dissection treated with TEVARwere added to a prospective
database. Demographic information, including age, gen-
der, comorbid conditions, chronicity of dissection, indica-
tion for procedure, operative details, and postoperative
Fig 1. A, Preoperative cross-sectional measurements. F
Postoperative cross-sectional measurements. From left
bosed), and total aorta.complications were recorded in the database. Acute dissec- aions were defined as presentations 14 days from the
nitial event.
For inclusion in this study, patients were required to
ave both preoperative and postoperative computed to-
ography angiography (CTA) to allow for measurement
omparison and volume calculation. Patients with Stanford
ype A dissections were excluded from the study.
Data collection. Preoperative and postoperative
TAs were analyzed using TeraRecon Aquarius Intuition
dition software (Foster City, Calif). In patients with
ultiple postoperative CTAs, the scan with the longest
ollow-up was used for postoperative volume calculations.
sing thin-cut (3 mm) three-dimensional reconstruction
mages, the centerline of the true lumen (TL) and false
umen (FL) were established from the left subclavian artery
LSA) to the aortic bifurcation. All diametric measurements
ere then taken perpendicular to the centerline. On cross-
ectional images, a series of manually placed points created
n outline marking the edge of the true lumen, false lumen,
nd total aorta, thereby allowing for measurement of the
inimum and maximum diameter and cross-sectional area
Fig 1).
The true lumen was contiguous with the ascending
eft to right: true lumen, false lumen, and total aorta. B,
ht: true lumen (with stent graft), false lumen (throm-rom l
to rigorta and the proximal intimomedial tear was identified in
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Volume 54, Number 4 Stanley et al 987the descending aorta in all cases. Postoperative false lumen
thrombosis was confirmed by observing an absolute lack of
contrast flow in the false lumen throughout the level of
endograft. Any blush of contrast in the false lumen, even in
the setting of partial thrombosis, was considered false lu-
men patency, placing these patients in the persistent false
lumen filling group.
Data processing. Volumetric measurements for the
true lumen, false lumen, and total aorta were calculated as
the sum of a series of irregular cylinders. To accommodate
the naturally variable size of the aorta in addition to the
irregular shape of each lumen in the setting of dissection,
the cross-sectional area was calculated at 5-cm intervals
along the centerline from the distal extent of the left
subclavian artery to the aortic bifurcation. The proximal
and distal cross-sectional area of each 5-cm segment was
then averaged to calculate the volume (Fig 2).
When the aortic bifurcation measured an intermediate
distance from the last 5-cm interval, that distance was used
as the height to calculate the distal-most segment volume.
The volume of the true lumen, false lumen, and total aorta
was then calculated as the sum of each segment from the
left subclavian artery to the aortic bifurcation. True and
false lumen volume index data were calculated by dividing
the true lumen volume and the false lumen volume, respec-
tively, by the volume of the total aorta, ie, TLVi  TL
volume/(TL volume  FL volume) and FLVi  FL vol-
ume/(TL volume  FL volume).
Statistical analysis. Statistical comparison was per-
formed between patients with and without postoperative
FLT. Data were expressed as mean  standard deviation.
Differences between the two groups were analyzed using
the Student t-test. Statistical significance was defined as
P  .05.
RESULTS
Patients. Between January 2006 and March 2010,
132 patients underwent thoracic aortic stent grafting at our
institution. Thirty-one patients (23%) had TEVAR for type
Fig 2. Schematic of aortic dissection volume measurements.
Green shading represents the false lumen. TL, true lumen; FL, false
lumen, A (1,2,3,4), area; h, height.B dissection. Preoperative and postoperative CTA images sere available for analysis in 23 of the 31 patients. The
emaining eight patients, without complete imaging, were
xcluded. Of those included, there was a male predomi-
ance of patients (n 17, 73.9%) with a mean age of 59
4 (range, 32-84) years. Mean postoperative follow-up
maging was 9 months (range, 3-39 months). Thirteen of
he 23 patients (57%) had postoperative false lumen throm-
osis, while 10 patients (43%) had persistent false lumen
lling after TEVAR.
Patient demographics and associated medical comor-
idities of included patients can be seen in Table I. The only
omorbidity found to be significantly different between the
roups on univariate analysis was hyperlipidemia. This is
ikely a statistical aberration and should be investigated
urther in a prospective study.
Of the 23 patients in this study, eight patients (35%)
ere treated for acute indications, including rupture (n 
), visceral or lower extremity malperfusion (n  3), un-
ontrollable hypertension (n 4), and refractory pain (n
). The remaining 15 patients (65%) were treated for
hronic indications, including aortic degeneration with an-
urysmal dilatation (n  13) and refractory pain (n  9).
he distal extent of the aortic dissection, as shown in Table
I, did not differ significantly between patients with or
ithout postoperative FLT.
Interventions. Patients were treated with a variety of
ortic endografts, including Medtronic Talent Thoracic
tent Graft System (Medtronic Cardiovascular, Santa Rosa,
alif) (n  11), Gore TAG Endoprosthesis (W. L. Gore
nd Associates, Flagstaff, Ariz) (n 11), and Cook Zenith
X2 (Cook Medical, Bloomington, Ind) (n  1). The
hoice of stent graft was left to the surgeon’s discretion and
as not significantly associated with postoperative false
umen patency or thrombosis. No individual stent graft
able I. Demographics of patients with type B aortic
issection
Postoperative
FL thrombosis
(n  13) n (%)
Postoperative
FL patency
(n  10) n (%) P value
ge (years) 60.1  10.7 58.9  15.8 NS
emale 3 (23) 3 (30) NS
ypertension 12 (92) 8 (80) NS
iabetes mellitus 2 (15) 1 (10) NS
obacco use 7 (54) 6 (60) NS
yperlipidemia 5 (38) 0 .03a
enal insufficiency 2 (15) 3 (30) NS
besity 2 (15) 0 NS
OPD 1 (8) 0 NS
ersonal history of
malignancy
2 (15) 0 NS
ongestive heart failure 0 1 (10) NS
revious aortic surgery 0 3 (30) NS
onnective tissue
disorder
0 1 (10) NS
OPD, Chronic obstructive pulmonary disease; FL, false lumen.
P  .05.howed a significant difference in the true or false lumen
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October 2011988 Stanley et alvolume change postoperatively. The technical success rate
was 100%.
The length of coverage of the thoracic aorta was max-
imized to the extent necessary for safe treatment of the
dissection. All but two patients had complete coverage of
the descending thoracic aorta from the LSA to a level just
proximal to the celiac artery. The two outlying patients had
coverage to the mid-descending thoracic aorta. The length
of aortic coverage was not found to be statistically signifi-
cant in this study.
The left subclavian artery was intentionally covered in
six of 13 patients (46%) with postoperative FLT, and three
of these patients received revascularization procedures
(carotid-subclavian bypass, n 2; left subclavian stent, n
1). In the persistent postoperative false lumen filling group,
six of 10 patients (60%) had coverage of the LSA with one
patient undergoing revascularization by fenestration and
stent placement. LSA coverage with or without revascular-
ization was not statistically significant between the groups.
No significant difference was identified in length of aortic
coverage, debranching of visceral vessels, or use of spinal
drains between the two groups (Table II).
Diametric measurements. Analysis of aortic mor-
phology began with the maximal descending thoracic aorta
diameter in the pre- and postoperative period. Patients with
postoperative FLT had a significantly smaller preoperative
aortic diameter than patients with persistent false lumen
filling (5.05  1.01 vs 6.30  1.45 cm; P  .02). Postop-
eratively, the maximum descending thoracic aorta diameter
remained significantly smaller in patients with FLT (4.82
Table II. Indications for thoracic endovascular aortic repa
Indication
Acute
Refractory pain
Uncontrolled hypertension
Visceral or distal ischemia
Rupture
Chronic
Aneurysmal enlargement/rapid expansion (5 mm/6 month
Refractory pain
Distal extent of dissection
Descending thoracic aorta
Celiac artery or SMA
Renal arteries
Iliac arteries
Vessels off false lumen
Visceral (celiac artery, SMA, IMA)
Renal arteries
Device
Gore TAG
Talent
Cook TX2
Left subclavian artery covered
Revascularization procedure
Spinal drain
FL, False lumen; IMA, inferior mesenteric artery; SMA, superior mesenteric1.30 vs 6.22  1.22 cm; P  .01). While not significantly Cifferent, the decrease in the mean aortic diameter was
reater in patients with postoperative FLT (0.23 vs 0.08
m; P  .72).
Volume and volume index calculations. Volume
alculations of the true lumen, false lumen, and total aorta
n the preoperative and postoperative setting are presented
n Table III. A significantly smaller preoperative true lumen
olume was seen in those patients with postoperative FLT,
owever, no significant difference in the preoperative vol-
me of the false lumen was observed. The total aorta
olume was considerably smaller in patients with postoper-
tive FLT, but this difference was not significant. Postop-
ratively, patients with FLT had significantly smaller false
umen and total aorta volumes. A significant increase be-
ween the mean preoperative and postoperative true lumen
olume was seen in patients with FLT (45.8% vs 10.9%;
 .02).
Volume index data assessed the relative volume of the
rue lumen or false lumen to the total aorta volume and
onfirmed the findings of the absolute volume analysis
Table IV). There was no significant difference between
reoperative TLVi or FLVi in either group, as these differed
y only a few percentage points. Patients with postopera-
ive thrombosis of the false lumen had a significant increase
n TLVi (0.427 vs 0.617; P  .02) and a significant
ecrease in FLVi (0.573 vs 0.383; P  .02). Significant
hanges were not seen in the TLVi (0.467 vs 0.477; P 
75) or the FLVi (0.533 vs 0.523; P .75) in patients with
ostoperative false lumen filling.
Because of the variable time frame of postoperative
EVAR), dissection characteristics, and operative details
Postoperative FL thrombosis
(n  13) n (%)
Postoperative FL filling
(n  10) n (%) P value
3 (23) 5 (50) .19
3 (23) 4 (40) .40
0 4 (40) .01
2 (15) 1 (10) .85
0 1 (10) .26
10 (77) 5 (50) .19
9 (69) 4 (40) .17
5 (38) 4 (40) .94
1 (8) 0 .39
2 (15) 0 .21
1 (8) 3 (30) .17
9 (69) 7 (70) .97
9 (69) 5 (50) .37
9 (69) 7 (70) .97
8 (61) 3 (30) .14
4 (31) 7 (70) .06
1 (8) 0 .39
8 (61) 8 (80) .36
6 (46) 1 (10) .06
3 (23) 3 (30) .72
.ir (T
s)TAs from which volume calculations were obtained, the
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Volume 54, Number 4 Stanley et al 989time to false lumen thrombosis and rate of change of each
lumen was not calculated. However, included are patients
with only one postoperative CTA as early as 3 months after
intervention, indicating that thrombosis occurs early in the
postoperative period.
Postoperative false lumen status. Patients included
in the postoperative false lumen thrombosis group showed
no evidence of blood flow in the false lumen along the
entire length of the stent graft on follow-up CTA.
Four of the 13 patients (31%) progressed to complete
thrombosis of the false lumen throughout the length of the
dissection. Of the remaining nine patients, six had evidence
of at least some thrombus formation in the false lumen
distal to the end of the stent graft, while three patients had
ongoing blood flowwithout thrombus in the false lumen of
the abdominal or infrarenal aorta. Additionally, three of the
10 patients (30%) in the postoperative false lumen filling
group had incomplete thrombosis of the false lumen at the
level of the stent graft. These findings were not statistically
different, and no significant sequelae have been identified
related to false lumen patency distal to the endograft.
Postoperative outcomes. All complications following
TEVAR in this study are listed in Table V. There were no
significant differences in the complication rates between
groups. In the postoperative FLT group, four patients
(31%) required five reinterventions. Two of these patients
required open surgery in the postoperative period. One
patient had retrograde aortic dissection extending from the
left subclavian artery to the proximal ascending aorta with
extension into the proximal innominate artery, requiring
ascending arch replacement. The other patient had reinter-
Table III. Mean volumes for the true lumen, false lumen,
Volume (cm3)
Postoperative
(n 
True lumen 141.3
Preoperative False lumen 224.6
Total aorta 431.5 
True lumen 206.1
Postoperative False lumen 155.4
Total aorta 412.0 
FL, False lumen.
Table IV. Pre- and postoperative volume indices of the
true and false lumen
Preoperative Postoperative P value
FL thrombosis (n  13)
TLVi 0.427 0.617 .02
FLVi 0.573 0.382 .02
FL filling (n  10)
TLVi 0.467 0.477 .75
FLVi 0.533 0.523 .75
FL, False lumen; FLVi, false lumen volume index; TLVi, true lumen volume
index.vention in a staged fashion for concurrent infrarenal ab- Iominal aortic and common iliac artery aneurysms, under-
oing coil embolization of the ipsilateral hypogastric artery
uring initial TEVAR placement, followed 1 month later
y hepatorenal bypass and endovascular aortic repair with
n iliac limb extender. Two additional patients underwent
oil embolization of the left subclavian artery for type 2
ndoleaks identified on surveillance CTA. The final patient
ad collapse of the distal endograft 2 weeks postoperatively,
hich was corrected by balloon profiling and additional
tent graft placement.
In the patent postoperative false lumen group, reinter-
ention was required in four patients (40%), two of which
equired open surgery in the postoperative period. One
atient presented approximately 7 weeks after TEVARwith
istal extension of the dissection leading to malperfusion
yndrome, requiring open mesenteric revascularization and
ower extremity bypass. This patient developed postopera-
ive hemodynamic instability, anuria, and acidosis, how-
ver, the patient’s family refused abdominal exploration
nd the patient expired thereafter. This was the only mor-
ality. The second patient developed a mediastinal hema-
oma from nonsurgical bleeding after median sternotomy
nd underwent exploration and evacuation of mediastinal
lot on postoperative day 1. The final patient underwent
roximal aortic cuff placement after development of a type
total aorta
hrombosis Postoperative FL filling
(n  10) P value
.1 230.4  92.6 .01
9.8 302.6  239.9 .34
68.3 597.6 / 240.5 .06
.4 255.8  58.6 .09
4.9 341.5  244.5 .02
50.8 698.3 / 268.8 .01
able V. Complications following thoracic endovascular
ortic repair (TEVAR)
omplication
FL thrombosis
(n  13),
n (%)
FL filling
(n  10), n (%) P value
cute renal failure 2 (15) 2 (20) .78
rinary tract infection 1 (8) 2 (20) .41
neumonia 0 1 (10) .26
ransient paralysis 0 2 (20) .10
ardiac arrhythmia 1 (8) 1 (10) .85
yocardial infarction 1 (8) 1 (10) .85
ransient ischemic attack 1 (8) 0 .39
ulmonary
thromboembolism
2 (15) 0 .21
ostoperative bleeding 1 (8) 1 (10) .85
etrograde dissection 1 (8) 1 (10) .85
eath 0 1 (10) .26
eintervention 4 (31) 4 (40) .66
L, False lumen.and
FL t
13)
 68
 13
/ 1
 66
 11
/ 1a endoleak.
c
c
f
d
p
T
s
r
a
p
w
e
p
n
f
f
w
i
r
d
o
p
4
p
H
t
t
d
p
n
4
g
t
w
t
p
a
d
a
s
f
C
t
v
b
n
c
c
a
d
l
w
JOURNAL OF VASCULAR SURGERY
October 2011990 Stanley et alDISCUSSION
TEVAR has proven to be a safe and efficacious treat-
ment option for type B dissection with lower morbidity and
mortality compared to open repair8-10,16-18 and has thus
encouraged liberalization of the indications for interven-
tion. Certainly, repair is indicated for all patients with
symptomatic (complicated) type B dissectionmanifested by
impending rupture, uncontrolled hypertension, malperfu-
sion syndrome, or unrelenting pain.4,11 In patients with
uncomplicated chronic disease, the indications for inter-
vention have been less clear but include aneurysmal degen-
eration and rapid expansion (5 mm/6 months). The
treatment of choice for the remainder of patients with type
B dissection has been medical management.
Unfortunately, optimal medical therapy comprised of
blood pressure and impulse control has not been associated
with optimal results.2,11,19 In fact, this therapy fails in 20%
to 40% of patients who eventually develop aneurysmal
degeneration or aortic rupture requiring surgical interven-
tion.1,12,19 Likewise, the Investigation of Stent Grafts in
Aortic Dissection (INSTEAD) study showed 20.6% of
medically treated patients were converted to endovascular
or open surgical treatment due to aortic dilatation 6
cm.19 Importantly, the imperfect results seen with medical
management may be explained, at least in part, by the
persistence of a chronically patent false lumen in up to 44%
of these patients.6
In separate studies of medically treated type B dissec-
tion patients, a patent false lumen predicted significantly
higher rates of aortic events necessitating surgical interven-
tion (ie, rupture, visceral or lower extremity ischemia, in-
crease of aortic diameter to 5 cm, or growth 5 mm per 6
months).3,6 Persistent false lumen patency has further been
demonstrated to be an independent risk factor for aneurysmal
degeneration,15 dissection-related rupture and death,13 while
false lumen thrombosis is protective against these outcomes.14
If not convinced by association studies alone, autopsy reviews
have shown that aortic rupture after typeBdissectionoccurs at
locations devoid of aortic thrombus, indicative of persistent
false lumen flow, even in patients with partial false lumen
thrombosis.20
It follows that exclusion and thrombosis of the false
lumen with resultant re-expansion of the true lumen are the
primary goals of TEVAR.21-23 This appears to be success-
fully accomplished by deploying the stent graft across the
proximal intimal tear to divert blood flow away from the
false lumen and preferentially down the true lumen. De-
spite the high rate of technical success in achieving proximal
seal after TEVAR for type B dissection,14 we cannot reliably
predict a successful clinical outcome. This indicates that
alternate factors, in addition to proximal seal, contribute to
postoperative FLT. We sought to identify pre- and postop-
erative aortic characteristics in patients with type B dissec-
tion that may contribute to false lumen thrombosis follow-
ing TEVAR.
In our analysis, preoperative diameter measurements
were significantly predictive of FLT after TEVAR. Specifi- cally, nonaneurysmal aortas (mean diameter 5.05 1.01
m) were significantly more likely to undergo postoperative
alse lumen thrombosis. Preoperative aneurysmal aortic
ilatation (mean diameter  6.30  1.45 cm) consistently
redicted persistent false lumen patency after TEVAR.
hese data confirm the findings of prior studies3,6,14,15 and
uggest that TEVAR is likely more effective with higher
ates of FLT when type B dissections are treated prior to
neurysmal degeneration.
Analysis of our volumetric data showed that smaller
reoperative true lumen volumes and total aorta volumes
ere significant and near-significant predictors of postop-
rative FLT, respectively. This confirms the findings of the
revious diameter measurements discussed above, ie, that
onaneurysmal aortas have higher rates of postoperative
alse lumen thrombosis.
Lastly, we analyzed the volume of the true lumen and
alse lumen as a percentage of the total aortic volume,
hich we termed the volume index. Use of the volume
ndex corrects for absolute size measurements, thereby
emoving differences in aortic length and size (ie, gender
ifferences) from consideration. This allows for evaluation
f additional factors contributing to FLT.
Index analysis revealed that all patients had a similar
reoperative true lumen percentage, comprising 42% to
6% of the aortic volume, and a similar false lumen
ercentage, comprising 53% to 57% of the aortic volume.
owever, after intervention, patients with false lumen
hrombosis had a significant increase in the percent of
he true lumen to a mean of 61.7% and a significant
ecrease in the percent of the false lumen. Patients with
ersistent postoperative false lumen filling had essentially
o change in the percent of the true lumen (mean 
7.7%) or false lumen (Table IV).
Therefore, it appears that it is the ability of the stent
raft to expand the true lumen and divert flow away from
he false lumen that determines success of TEVAR. In other
ords, the ability of the stent graft to significantly increase
he true lumen volume as a percent of the total aorta will
redict false lumen thrombosis. In a smaller-diameter, non-
neurysmal aorta, the relative size of the stent graft after
eployment produces a significant increase in the volume
nd percentage of the true lumen with a concomitant
ignificant decrease in the volume and percentage of the
alse lumen, leading to false lumen thrombosis (Fig 3).
onversely, in the larger, aneurysmal aorta, deployment of
he relatively small stent graft has little effect on the total
olume or percentage of the true lumen, fails to divert
lood flow away from the false lumen, and therefore does
ot change blood flow dynamics significantly enough to
ause thrombosis.
Additionally, the current study did not show a signifi-
ant difference in false lumen thrombosis rates between
cute and chronic dissections. Kusagawa, et al15 previously
emonstrated that 76% of patients obliterated the false
umen after stent grafting in acute type B dissection,
hereas only 36% had false lumen thrombosis in the
hronic type B dissection group. Interestingly, the patients
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Volume 54, Number 4 Stanley et al 991with chronic type B dissection included in that study also
had consistently larger aortic diameters than those with
acute dissection, but the aortic diameter was5 cm in both
groups. Our current data may provide a sound explanation
for the success in Kusagawa’s study, suggesting it is the
diameter of the aorta at the time of stent grafting, and not
the time since dissection, that predicts postoperative false
lumen thrombosis.
This study has several limitations. First, it is a retrospec-
tive review and comes with the inherent biases therein.
Second, the small numbers of patients in each group limits
the power of the study and may increase the standard error of
the mean of our measurements. Finally, the mean follow-up
time of this study (9 months) is short. Aortic remodeling
continues in the post-TEVAR period and may be more
significant in patients with thrombosis of the false lu-
men.17,18,20 A prospective study with protocol-driven CTA
scans and longer follow-up reaching more than 5 years
would be ideal for further investigation.
In conclusion, we remain strong proponents of treating
type B dissection with endovascular stent grafts to promote
postoperative false lumen thrombosis, combined with op-
timal medical management. When considered with the
results of recently published studies, our data begin to
define subgroups that are likely to have the highest success
rates with TEVAR and therefore the most promising long-
term outcomes.
TEVAR remains the treatment of choice for compli-
cated type B dissection in both the acute and chronic
setting. We demonstrated an increased likelihood of signif-
icant re-expansion of the true lumen with corresponding
false lumen thrombosis in patients with a nonaneurysmal
Fig 3. Schematic of changes in true lumen volume index (TLVi)
and false lumen volume index (FLVi). Green shading represents
the false lumen.aorta. Thus, our results suggest that it is the aortic diameternd not the timing after dissection that best predicts false
umen thrombosis after TEVAR.
Finally, evidence that optimal medical treatment with
lose surveillance is indeed the best therapeutic option for
ncomplicated type B dissection is compelling, although
esults at 5-year follow-up may be more revealing. While
he role of TEVAR in the acute, uncomplicated setting
emains in question, high-risk patients with multiple med-
cal comorbidities or noncompliant patients who have a low
ikelihood of follow-up should be considered for early
urgical therapy. TEVAR may have limited success in
hronic aneurysmal type B dissection, however, the mor-
idity and mortality associated with open repair is not an
ppealing option. Further study should continue to clarify
urgical indications for each subgroup.
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Dr Eugene M. Langan, III (Greenville, SC). Dr Stanley and
Colleagues from the University of Texas Southwestern present an
interesting study on patients with type B aortic dissections treated
with TEVAR that underwent volumetric analysis. Their premise is
that false lumen thrombosis is a key to successful long term
outcomes. They treated 31 patients over 50 months and have
follow-up imaging on 23 patients or 74%. The majority of the
patients treated with TEVAR were treated for chronic indications.
False lumen thrombosis was achieved in 13 of 23 patients or 57%.
Patients with false lumen thrombosis had statistically significant
increased TLVi and decreased FLVi. There was one mortality and
8 patients or 35% required re-intervention with no difference
between the two study groups.
This is an appealing study and the most important fact that I
take away is that there is increased false lumen thrombosis on the
patients treated with TEVAR when the aneurysm is approximately
5 cm or less. This could influence decision making during the
follow-up phase of patients with type B aortic dissections being
treated medically.
I have three questions for the authors:
1. In the manuscript you suggest early intervention with
TEVAR on patients that present with type B aortic dissection
and infer with or without complications. Yet you reference the
INSTEAD study that show only 20.6% of patients treated
medically come to either open or endo repair. Then you push
for early repair on patients that may be difficult, or lost to
follow-up when you have incomplete imaging on 26% of your
patients. With these facts and a complication/re-intervention
rate of 35% would it not be better to medically these patients
and follow them and intervene before they enlarge to a diameter
 5 cm as suggested by your findings?
2. You show that false lumen thrombosis is a key to better long
term outcomes, was there any attempt to cover both proximal
and distal entry and re-entry points when possible?
3. Our data has shown that when following patients long term
with type B aortic dissections there is an increasedmortality rate
unrelated to the dissection suggesting this is a systemic condi-
tion with poor prognostic indications. Although your average
follow-up was only 9 months do you think these patients are
indeed sicker and may have increased mortality?Dr Gregory A. Stanley. Thank you, Dr Langan, for your
omments and questions. In response to your first question, the
esults of the INSTEAD study include data for a follow-up period
f 24 months, and as such, may not be telling the whole story.
ates of conversion to open or endovascular intervention in med-
cally treated patients is as high as 40% in some studies, so the mid-
nd long-term surgical intervention rates of the INSTEAD trial
ay shed more light on the natural history of this disease with
urrent management strategies. Many of our patients receive pre-
nd post-operative imaging and follow-up at outside facilities
ithin our referral area, which accounts for our lower inclusion
ercentage due to lack of imaging. I would still favor early inter-
ention before aneurysmal dilatation, especially in patients at high
isk of being lost to follow-up, because our ability to induce false
umen thrombosis with TEVAR is limited with increasing diameter
nd size of the aorta. Our data suggests that the mean diameter of
-cm is still amenable to inducing false lumen thrombosis and may
e a good benchmark for intervention. Requiring more secondary
rocedures after TEVAR would not deter me knowing that false
umen thrombosis, and thus a better outcome, is achievable.
To answer your second question, we attempt to cover as many
enestrations as possible in the thoracic aorta, but coverage of the
roximal entry tear is our ultimate goal. All of these patients have
ultiple septal fenestrations along the length of the dissection, and
ften distal re-entry points are in the abdominal aorta that are not
menable to coverage. Interestingly, only four patients in our study
ad complete false lumen thrombosis including the distal dissec-
ion, so the majority have retrograde filling distal to the stent graft
nd that remains to be a risk factor for long-term complications.
Finally, I agree with the theory that this is a systemic condi-
ion, and that these patients have a poorer prognosis overall. I
uestion whether the dissection is a marker of an underlying
ystemic condition or if the dissection adds an inflammatory me-
iator leading to future systemic problems and perhaps mortality.
n either case, we know that false lumen thrombosis is associated
ith better outcomes, and we are only now beginning to under-
tand the factors that will reliably predict who will achieve that
esult after TEVAR. The data in this study shows that if you can
ignificantly increase the volume percent of the true lumen relative
o the total size of the aorta, post-operative false lumen thrombosis
an be consistently expected.
